2020-2025 Global R-Salbutamol Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma.
This report elaborates the market size, market characteristics, and market growth of the R-Salbutamol industry, and breaks down according to the type, application, and consumption area of R-Salbutamol. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for R-Salbutamol in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global R-Salbutamol market covered in Chapter 13:
Dey Pharma L.P.
Medican Pharma Incorporated
Technilab Pharma Inc.
Appco Pharma Llc
Teva Respiratory, LLC
Boehringer Ingelheim (Canada) Ltd Ltee
Preferreed Pharmaceuticals Inc.
Valeant Canada Lp Valeant Canada S.E.C.
Rpk Pharmaceuticals, Inc.
Apotex
TYA Pharmaceuticals
Amneal Pharmaceuticals
Mylan Specialty
A-S Medication Solutions
Baker Cummins Inc
Physicians Total Care, Inc.

In Chapter 6, on the basis of types, the R-Salbutamol market from 2015 to 2025 is primarily split into:
Oral
Respiratory

In Chapter 7, on the basis of applications, the R-Salbutamol market from 2015 to 2025 covers:
Hospital
Pharmacy

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025